Greenwich LifeSciences Files Q1 2025 10-Q
Ticker: GLSI · Form: 10-Q · Filed: May 20, 2025 · CIK: 1799788
| Field | Detail |
|---|---|
| Company | Greenwich Lifesciences, Inc. (GLSI) |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
GRNV Q1 2025 10-Q filed. Financials updated.
AI Summary
Greenwich LifeSciences, Inc. filed its Q1 2025 10-Q report on May 20, 2025, covering the period ending March 31, 2025. The company, based in Stafford, Texas, operates in the pharmaceutical preparations sector. Financial details for the quarter and comparative periods are presented, including common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with the latest financial performance and position of Greenwich LifeSciences, Inc. for the first quarter of 2025, crucial for understanding the company's ongoing operations and financial health.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Greenwich LifeSciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of fiscal year 2025, ending March 31, 2025.)
- 20250520 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Greenwich LifeSciences, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250520 (date) — Date the report was filed
- Stafford, TX (location) — Company's business and mailing address
FAQ
What were the key financial figures for Greenwich LifeSciences in Q1 2025?
The filing provides details on common stock, additional paid-in capital, and retained earnings for the period ending March 31, 2025, and comparative periods, but specific dollar amounts for revenue or net income are not detailed in this header information.
When was this 10-Q report filed?
This 10-Q report was filed on May 20, 2025.
What is the primary business of Greenwich LifeSciences, Inc.?
Greenwich LifeSciences, Inc. operates in the Pharmaceutical Preparations industry, SIC code 2834.
Where is Greenwich LifeSciences, Inc. located?
The company's business and mailing address is 3992 Bluebonnet Dr, Building 14, Stafford, TX 77477.
What fiscal year end does Greenwich LifeSciences, Inc. observe?
Greenwich LifeSciences, Inc. observes a fiscal year end of December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Greenwich LifeSciences, Inc. (GLSI).